Filtros de búsqueda

Lista de obras de

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.

artículo científico publicado en 2015

A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients

artículo científico publicado en 2014

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment

artículo científico publicado en 2017

Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study

artículo científico publicado en 2002

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

artículo científico publicado en 2003

Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences.

artículo científico publicado en 2017

Cyclo-oxygenase inhibition in colorectal adenomas and cancer

artículo científico publicado en 2003

Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

artículo científico publicado en 2007

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

artículo científico publicado en 2013

Epidermal growth factor receptor as a major anticancer drug target

artículo científico publicado en 2006

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.

artículo científico

First line targeted therapies in breast cancer: focus on bevacizumab

artículo científico publicado en 2007

First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II study

artículo científico publicado en 2003

Gastric cancer. Treatment of advanced disease and new drugs.

artículo científico publicado en 2005

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?

artículo científico publicado en 2013

Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.

artículo científico publicado en 2016

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

scientific article published on 11 December 2004

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

scientific article published on 19 July 2016

Medical treatment of gastrointestinal stromal tumors: state of the art and future perspectives

artículo científico publicado en 2006

Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences

artículo científico publicado en 2017

Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors

artículo científico publicado en 2005

New emerging drugs in soft tissue sarcoma

artículo científico publicado en 2006

New treatment approaches in renal cell carcinoma

artículo científico publicado en 2009

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

artículo científico publicado en 2006

Phase I study of temozolomide and lomustine in the treatment of high grade malignant glioma

artículo científico publicado en 2006

Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer

artículo científico publicado en 2006

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

artículo científico publicado en 2005

Prognostic and predictive response factors in colorectal cancer patients: between hope and reality

artículo científico publicado en 2014

Prognostic value of CD40 in adult soft tissue sarcomas.

artículo científico publicado en 2004

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

artículo científico publicado en 2016

Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.

artículo científico publicado en 2006

Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.

artículo científico publicado en 2006

Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

artículo científico publicado en 2003

Submicron complex lipid carriers for curcumin delivery to intestinal epithelial cells: Effect of different emulsifiers on bioaccessibility and cell uptake.

artículo científico publicado en 2015

Surface modified zeolite-based granulates for the sustained release of diclofenac sodium

artículo científico publicado en 2016

The proteasome: a worthwhile target for the treatment of solid tumours?

artículo científico publicado en 2007

Transcatheter arterial procedures in the treatment of patients with hepatocellular carcinoma: a review of literature

artículo científico publicado en 2003

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

artículo científico publicado en 2016

Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy

artículo científico publicado en 2010

[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab].

artículo científico publicado en 2015